InvestoGain Australia

SEARCH LISTED COMPANY

ANY AUS OR NZ COMPANY

BROWSE

Browse Australian listed companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

BROWSE

Browse Australian listed companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse Australian delisted companies/archived funds or use SEARCH

SEARCH PRIVATE COMPANY

SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

INOVIQ LTD(IIQ)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 FROMTO
INOVIQ LTD09/12/2021
BARD1 LIFE SCIENCES LIMITED14/06/201609/12/2021
EUROGOLD LIMITED28/05/200214/06/2016
ESMERALDA EXPLORATION LIMITED28/05/2002

Shareholder links

 

REGISTRY:

Level 17, 221 St Georges Terrace, Perth WA 6000

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000196149
Address: Unit 202, Level 2 39 Mends Street South Perth WA 6151
Tel:  +61 8 9381 9550 Fax: +61 8 9388 7559

Date first listed: 18/04/1991
Company Secretary: 
Sector: Health Care Equipment & Services Industry Group: XMJ
Activities: Developing and commercialising cancer diagnostic products

News & Events

Expand this box to read and print

The suspension of trading in the securities of Inoviq Ltd will be lifted immediately following the release by IIQ of an announcement providing further disclosure regarding matters referred to in IIQ's price query response released on 28 May 2025. ASX is conducting continued enquiries into IIQ's compliance with the Listing Rules in relation to its suspension under Listing Rule 17.3.

02/06/2025

The company has developed an AI-enhanced ovarian cancer test, which achieved 77% sensitivity and 99.6% specificity for early detection of ovarian cancer across all stages. The test accurately detected all early-stage I and II cancers without missed diagnoses. IIQ plans to advance the screening test to the market.

02/06/2025

The securities of Inoviq Ltd were placed in a trading halt on 26 May 2025 pending the release of a price query response. IIQ's securities will now be suspended from quotation immediately under Listing Rule 17.3 pending further disclosure regarding matters referred to in IIQ's price query response released today.

28/05/2025

name changed from Bard1 Life Sciences Limited

09/12/2021

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...

     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    10/03/2025Philip Powell50,000$0.350$17,500.00
    10/03/2025Max Johnston200,000$0.350$70,000.00
    06/03/2023Philip Powell20,000$0.570$11,400.00
    03/03/2023Philip Powell57,999$0.553$32,091.00
    13/05/2022Philip Powell20,000$0.531$10,620.00

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    David WilliamsNon Exec Chairman29/11/2023
    Leearne HinchCEO07/11/2016
    Mark EdwardsCFO, Company Secretary02/11/2022
    Mary HarneyNon Exec Director01/10/2024
    Geoffrey CummingNon Exec Director28/07/2020
    Max JohnstonDirector18/06/2019
    Philip PowellDirector18/06/2019

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION

    Date of first appointment, title may have changed.